Form 8-K - Current report:
SEC Accession No. 0001023024-06-000009
Filing Date
2006-03-31
Accepted
2006-03-31 11:22:44
Documents
3
Period of Report
2006-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR 2005 YEAR END RESULTS yearend2005-8k.htm 8-K 28644
2 PRESS RELEASE ISSUED MARCH 31, 2006 pressrelease.htm EX-99.1 24034
3 BIOSANTE LOGO biosantelogo6.jpg GRAPHIC 10177
  Complete submission text file 0001023024-06-000009.txt   68502
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 06726171
SIC: 2836 Biological Products, (No Diagnostic Substances)